FDA 483 - Zhuhai United Laboratories Co. Ltd. - August 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Zhuhai United Laboratories, Co., Ltd. in Zhuhai, China, an API Intermediate Manufacturer, was inspected by the FDA. The inspection revealed significant deficiencies across quality control, laboratory practices, production records, and equipment maintenance. Key issues include inconsistent specifications with the Drug Master File, inadequate investigation of unexpected chromatographic occurrences, poor control of recovered solvents, incomplete laboratory and batch production records, deficient cleaning procedures, and unsuitable analytical testing methods.
ID · ae16ada7-7e83-490f-ae71-a25c5f14a6ac